Company Logo

84.13 USD

-4.32 (-4.89%)

Last updated Oct 30, 1:30 PM

Yesterday High

$93.05

Yesterday Low

$85.50

52w High

$176.19

52w Low

$38.05

Market Cap.

$2.8B

52w Change

121.10%

This is a preview of the full version of Prosperse

Trending News

KIDS Stock Gains From Its New Enabling Technologies Division Launch
KIDS Stock Gains From Its New Enabling Technologies Division Launch

OrthoPediatrics Corp. (KIDS) has launched its Enabling Technologies division, which will leverage the company's core mission of addressing unmet pediatric needs in orthopedics. The new division is expected to differentiate KIDS' core business, generate sustainable revenue growth, and gain access to ...

Zacks

Sep 16, 2024

Paragon 28 Stock Gains From the Latest Launch of Its Right-Angle Drill
Paragon 28 Stock Gains From the Latest Launch of Its Right-Angle Drill

Paragon 28 has launched a new Right-Angle Drill for its APEX 3D Total Ankle Replacement System, which is expected to improve the long-term success of ankle replacements. The company's stock gained 3.1% following the launch.

Zacks

Sep 11, 2024

Why Shares of TransMedics Stock Plunged This Week
Why Shares of TransMedics Stock Plunged This Week

TransMedics, a leader in organ transplant technologies, has seen its stock price experience wild volatility due to its revolutionary Organ Care System, high sales growth, and newfound profitability. Despite the company's first-mover advantage, its valuation remains high, requiring a long-term invest...

Josh Kohn-Lindquist

Sep 5, 2024

Can TransMedics (TMDX) Run Higher on Rising Earnings Estimates?
Can TransMedics (TMDX) Run Higher on Rising Earnings Estimates?

TransMedics (TMDX) has seen a significant improvement in its earnings outlook, with analysts raising their estimates for the company. This positive trend in earnings estimate revisions is driving the stock's performance and could continue to push it higher.

Zacks Investment Research

Aug 7, 2024

Compared to Estimates, TransMedics (TMDX) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, TransMedics (TMDX) Q2 Earnings: A Look at Key Metrics

TransMedics reported strong Q2 2024 earnings, with revenue up 117.9% year-over-year and EPS of $0.35 compared to -$0.03 in the prior year. The company's performance exceeded analyst estimates across key metrics like geographic revenues and net revenue by product line.

Zacks.Com

Aug 2, 2024

Why TransMedics Group Stock Is Soaring Today
Why TransMedics Group Stock Is Soaring Today

TransMedics Group (TMDX) reported strong Q2 results, with revenue up 118% year-over-year and net income of $12.2 million. The company also raised its full-year revenue guidance. The stock gained 11.1% on the news.

Keith Speights

Aug 1, 2024

Login to view more news

Dive into the world of investing with Prosperse

Explore our recent articles to learn more about how Prosperse can help you achieve your financial goals.

Read more news from Prosperse